Motor Neurone Disease Public Lecture Event as iCalendar

29 November 2016

5:30 - 8pm

Venue: CBR Seminar Room, Building 501, Room 505

Location: Faculty of Medical and Health Sciences

Host: Professor Christopher Shaw

Cost: Free

Contact info: RSVP to Mirelle Powell

Contact email: m.powell@auckland.ac.nz

Jarred Griffin 4

Why MND?

While studying Neurobiology in Cambridge, Professor Shaw met two families with an inherited form of MND, which sparked a life-long interest in assisting people with MND in the Clinic and seeking a better understanding of the disease in the laboratory.

Professor Shaw is determined to discover the gene defects that cause MND. Using a variety of cellular and biological models, his research is exploring disease mechanisms to advance drug discovery.

 

About Professor Christopher Shaw

Christopher Shaw is Professor of Neurology and Neurogenetics, Head of the Department of Clinical Neuroscience, Director of the Medical Research Council Centre for Neurodegeneration Research and Director of the Wohl Clinical Neuroscience Institute at the Institute of Psychiatry, King's College London.

He is an Honorary Consultant Neurologist at King's College Hospital where he directs a clinic for patients with motor neuron disease (MND, also known as amyotrophic lateral sclerosis). His early training in General Medicine and Neurology was conducted in New Zealand. He came to the UK in 1992 on a Wellcome Trust New Zealand Health Research Council Fellowship.

While studying Neurobiology in Cambridge he met two families with an inherited form of MND. This sparked a life-long interest in assisting people with MND in the Clinic and seeking a better understanding of the disease in the laboratory. He moved to the Institute of Psychiatry in 1995 and established a laboratory focussed on hunting down MND-causing gene defects. He has used these to explore disease mechanisms using a variety of cellular and animal models to advance drug discovery.